About this trial
The goal of this observational study is to evaluate the effectiveness and impact of Enhanced Recovery After Surgery (ERAS) on patients with pituitary gland tumors.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Clinical diagnosis of pituitary tumors
To sign a written informed consent form
Disqualifiers
Diagnosed with other malignant tumors
Severe infections, such as osteomyelitis, acute inflammation at the affected site, or open wounds at the treatment area
Pregnant women
Coagulation disorders or those taking anticoagulant medication
Trial population
Pituitary tumors, primarily benign growths, develop in the pituitary gland situated in the sellar region. This gland plays a pivotal role in regulating vital body functions including growth, metabolism, and various hormonal functions. As these tumors enlarge, they may press on adjacent areas and impair the gland's functions, leading to symptoms like headaches, vision issues, and hormonal imbalances. The principal treatment for pituitary tumors is surgery, aiming to excise the tumor from the brain's base. This procedure alleviates pressure on the pituitary gland and nearby structures, aiming to reinstate the gland's normal functionality.
Trial design
Case-control
Prospective
Treatments tested in this trial
Malnutrition Universal Screening Tool
Diagnostic testThe Malnutrition Universal Screening Tool (MUST) is a commonly used tool for assessing the nutritional status of adult patients. It is designed to identify early whether a patient is at risk of malnutrition or is already malnourished, enabling timely intervention and treatment. MUST includes three main assessment criteria: Body Mass Index (BMI): Degree of Weight Loss: This assesses the patient's weight change over the past three months, with grading based on the extent of weight loss. Effect of Illness on Dietary Intake: This evaluates the impact of illness on the patient's dietary intake, with grading based on the reduction in dietary intake. By combining the grades from these three assessment indicators, a final MUST score is obtained to determine the patient's nutritional status and level of risk. Based on the MUST score, patients can be categorized as low risk, medium risk, or high risk for malnutrition.
TIB Olfactory Test Device
DeviceOlfactory testing is conducted on patients undergoing pituitary tumor surgery via nasal endoscopy using the TIB Olfactory Test Device (TIBSIT). This testing aims to compare olfactory (sense of smell) outcomes before and after the surgery. The olfactory tests are performed preoperatively and then again at the 3-month postoperative mark to assess any changes or impacts on the sense of smell due to the surgery.
Apfel Score for Postoperative nausea and vomiting
Diagnostic testNausea and Vomiting Risk Scale: Apfel Score Risk Factors: Female; Smoking habit; History of postoperative nausea and vomiting or motion sickness; Use of opioid painkillers post-surgery (Each risk factor scores 1 point; minimum score is 0; maximum score is 4) Score Probability of Postoperative Nausea and Vomiting 0 - 10% 1. \- 21% 2. \- 39% 3. \- 61% 4. \- 79%
The American Society of Anesthesiologists (ASA) Physical Status Classification
Diagnostic testASA I: A normal, healthy patient with no systemic disease. ASA II: A patient with mild systemic disease. ASA III: A patient with severe systemic disease that limits activity but is not incapacitating. ASA IV: A patient with severe systemic disease that is a constant threat to life. ASA V: A moribund patient not expected to survive without the operation. This project involves collecting data from adult patients aged 20 to 75 years old who are classified as ASA I to III grade.
Short Form-36
BehavioralThe Short Form-36 (SF-36) is a widely used health assessment tool, extensively applied in both research and clinical practice. It is a concise yet comprehensive questionnaire designed to evaluate individuals' health status and quality of life. The SF-36 covers eight different dimensions of health, including physical functioning, bodily pain, general health, vitality, social functioning, emotional health, mental health, and health change. Each dimension is assessed through a series of questions that address aspects such as an individual's capabilities in daily life, symptoms, and emotional states. The SF-36 allows healthcare professionals and researchers to gain insights into a person's health and quality of life across these varied aspects. Additionally, SF-36 has undergone extensive testing and validation, proving to have good reliability and validity.
World Health Organization Quality of Life questionnaire (WHOQOL-BREF)
BehavioralThe World Health Organization Quality of Life questionnaire (WHOQOL-BREF) is a health-related quality of life assessment tool developed by the World Health Organization (WHO). It is designed to evaluate an individual's satisfaction with their life and overall health status. The WHOQOL-BREF is a condensed version of the original WHOQOL-100 questionnaire, intended to reduce the time required to complete it and enhance its applicability.
BDI-II(Beck Depression Inventory-II)
BehavioralThe BDI-II consists of 21 questions that assess the degree of depression by asking respondents about various depressive symptoms they have experienced. These symptoms include sadness, insomnia or oversleeping, changes in appetite, self-blame, self-disdain, loss of interest in daily activities, and more. Each question has four possible response options, allowing respondents to choose the answer that best fits their feelings. Scoring on the BDI-II ranges from 0 to 63, with higher scores indicating more severe depression. Based on the scores, the severity of a respondent's depression can be classified into different levels, ranging from mild to severe. The purpose of using this scale is to help healthcare professionals assess a patient's depressive symptoms, monitor changes in condition, and evaluate the effectiveness of treatments.
ERAS Patient Satisfaction Questionnaire(ERAS-PSQ)
BehavioralThe ERAS Patient Satisfaction Questionnaire (ERAS-PSQ) is a satisfaction survey specifically designed for patients who have undergone treatment following the Enhanced Recovery After Surgery (ERAS) protocols. This questionnaire aims to evaluate the patients' satisfaction and experience with the ERAS approach. Typically, it includes questions about various aspects of their treatment and care, such as pain management, the recovery process, the quality of nursing care, and communication with the medical team. The ERAS-PSQ is an important tool for assessing how well the ERAS protocols are received by patients and for identifying areas for improvement in patient care within the ERAS framework.
Quality of Recovery-40(QoR-40)
BehavioralThe Quality of Recovery-40 (QoR-40) is a widely used questionnaire designed to assess the quality of recovery after surgery. It comprises 40 questions that cover both physical and psychological aspects of a patient's recovery, such as pain, nausea, anxiety, dietary habits, and social functioning. The QoR-40 provides a comprehensive view of a patient's postoperative recovery, encompassing a range of factors crucial to understanding the effectiveness of surgical procedures and the overall patient experience during the recovery phase. This tool is instrumental in evaluating and improving post-surgical care and patient outcomes.
Treatment groups
Trial outcomes
Primary outcomes
Surgical complications
any complications associated with this operation
Postoperative pain assessment
describe postoperative Visual analogue scale (VAS) for pain assessment; the minimum value is 0 (no pain) and maximum value is 10 (most pain)
Postoperative vomiting assessment
describe postoperative vomiting status; 0=no; 1=mild, 2=moderate, 3=severe
Postoperative nausea assessment
describe postoperative nausea status; 0=no; 1=mild, 2=moderate, 3=severe
Secondary outcomes
Psychological stress- BDI-II
using Beck Depression Inventory-II, assessment of Psychological stress before and after surgery
Psychological stress- QoR-40
using Quality of Recovery-40, assessment of Psychological stress before and after surgery
Quality of life: Short Form-36
assessment of Quality of life before and after surgery
Quality of life: WHOQOL-BREF
assessment of Quality of life before and after surgery
Sponsors and contacts
Click on the lead sponsor to view all of their trials.